A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection

Clinical trial NCT05612581 · COMPLETED

Trial details

NCT number: NCT05612581
Sponsor: Vir Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2023-05-10
Primary completion: 2024-10-15
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.